BRIEF published on 05/31/2024 at 17:03, 1 year 8 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA FDA Approval Moderna Vaccine RSV MRESVIA
BRIEF published on 05/31/2024 at 17:03, 1 year 8 months ago Moderna reçoit l'approbation de la FDA américaine pour le vaccin contre le RSV mRESVIA Approbation De La FDA Moderne VRS MRESVIA Vaccin
PRESS RELEASE published on 05/31/2024 at 16:58, 1 year 8 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) Moderna gains FDA approval for mRESVIA, a single-dose pre-filled syringe RSV vaccine for adults 60+ to prevent lower respiratory tract disease. Second mRNA product and breakthrough therapy designation FDA Approval Moderna RSV Vaccine MRNA MRESVIA
BRIEF published on 05/22/2024 at 13:05, 1 year 8 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Clinical Trials Immunotherapy Moderna ASCO 2024 MRNA-4157
BRIEF published on 05/22/2024 at 13:05, 1 year 8 months ago Moderna annonce que les données seront présentées lors de l'assemblée annuelle 2024 de l'ASCO Immunothérapie Essais Cliniques Moderne ASCO 2024 ARNm-4157
PRESS RELEASE published on 05/22/2024 at 13:00, 1 year 8 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Moderna to host an investor event via webcast on June 3 at 6:15 PM CDT. Abstracts on mRNA-4157 for ASCO Annual Meeting. Details on mRNA-4157 (V940) therapy development Webcast Moderna Investor Event MRNA-4157 Neoantigen Therapy
BRIEF published on 05/13/2024 at 13:05, 1 year 8 months ago Moderna Announces Participation in Key Investor Conferences Investor Conferences Healthcare Financial Markets Moderna Webcasts
BRIEF published on 05/13/2024 at 13:05, 1 year 8 months ago Moderna annonce sa participation à des conférences clés pour les investisseurs Marchés Financiers Soins De Santé Conférences Investisseurs Moderne Webdiffusions
PRESS RELEASE published on 05/13/2024 at 13:00, 1 year 8 months ago Moderna to Present at Upcoming Conferences in May/June 2024 Moderna, Inc. to participate in upcoming investor conferences, showcasing its leadership in mRNA medicine and innovative approach to disease treatment. Live webcasts available Investor Conferences Moderna Inc. MRNA Medicine Webcasts Disease Treatment
BRIEF published on 05/02/2024 at 12:35, 1 year 9 months ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
Published on 02/09/2026 at 22:00, 20 minutes ago Amdocs Recognized as the Current Company to Beat in the 2025 Gartner AI Vendor Race: Amdocs Is the Company to Beat for AI in CSP Business Support Systems
Published on 02/09/2026 at 15:00, 7 hours 20 minutes ago Gungnir Resources Inc. Announces Management And Board Changes
Published on 02/09/2026 at 14:15, 8 hours 5 minutes ago White Gold Corp. Appoints Seasoned Mining Executive Donovan Pollitt as Strategic Advisor
Published on 02/09/2026 at 14:00, 8 hours 20 minutes ago Paymetrex Secures First U.S. License Payment
Published on 02/09/2026 at 14:00, 8 hours 20 minutes ago Geophysics Converge Ahead of Colosseum Deeper Drill Program
Published on 02/09/2026 at 19:59, 2 hours 20 minutes ago EQS-Adhoc: BOOSTER Precision Components Holding GmbH is not pursuing its planned bond issue and will initiate a written procedure to amend the bonds terms of its existing bond 2022/26
Published on 02/09/2026 at 19:00, 3 hours 20 minutes ago Atlassian Williams F1 Team toasts new partnership with Estrella Galicia 0,0
Published on 02/09/2026 at 19:00, 3 hours 20 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 02 FEVRIER 2026 au 06 FEVRIER 2026
Published on 02/09/2026 at 18:32, 3 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/09/2026 at 18:00, 4 hours 20 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 4 hours 35 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 4 hours 35 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 4 hours 35 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 4 hours 35 minutes ago Déclaration des droits de vote à fin janvier 2026
